What is the recommended dose of albumin for a patient with cirrhosis undergoing large-volume paracentesis of 4 liters of ascitic fluid?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Albumin Dosing for 4 Liters of Ascitic Fluid Removal

For a 4-liter paracentesis in cirrhosis, albumin is generally not required, as the threshold for mandatory albumin administration is >5 liters; however, if the patient has acute-on-chronic liver failure or high risk for acute kidney injury, administer 24-32 grams of albumin (6-8 g/L × 4 L). 1, 2

Standard Dosing Algorithm

Volume-Based Decision Making

For paracentesis <5 liters:

  • Albumin is not routinely indicated in standard-risk patients, as paracenteses removing <5 liters do not cause significant hemodynamic changes 3, 2
  • The 5-liter threshold is the established cutoff where post-paracentesis circulatory dysfunction becomes clinically significant 3, 1, 2

If albumin is administered for 4 liters (high-risk scenarios only):

  • Calculate: 6-8 grams per liter removed 1, 2
  • Total dose: 24-32 grams of albumin for 4 liters 2
  • Use 20% or 25% albumin solution 1

High-Risk Patients Who May Require Albumin Despite <5 Liters

The International Club of Ascites recommends considering albumin (8 g/L) even with <5 liters removed in specific high-risk situations: 1

  • Acute-on-chronic liver failure (ACLF) patients should receive 6-8 g/L regardless of volume removed 3
  • Patients at high risk of acute kidney injury post-paracentesis 1
  • Elevated baseline creatinine or blood urea nitrogen 3
  • Severe liver dysfunction (high MELD score, bilirubin >4 mg/dL) 1

Evidence Quality and Nuances

Why the 5-Liter Threshold Exists

The evidence strongly supports that single 5-liter paracenteses without albumin do not cause deleterious hemodynamic or renal effects in standard patients. 3 However, an important RCT demonstrated that daily 5-liter paracenteses without albumin resulted in acute kidney injury in 21% of patients, while no patients receiving albumin developed AKI. 3 This study also showed significant increases in plasma renin activity and aldosterone 48 hours post-paracentesis in the control group but not in the albumin group. 3

Superiority of Albumin Over Alternatives

When albumin is indicated, it is definitively superior to other plasma expanders: 2

  • Post-paracentesis circulatory dysfunction occurred in 18.5% with albumin vs 34.4% with dextran-70 vs 37.8% with poligelina 2
  • Albumin reduces odds of circulatory dysfunction by 61% (OR=0.39) compared to other treatments 2
  • Albumin reduces mortality by 36% (OR=0.64) 2
  • Albumin reduces hyponatremia by 42% (OR=0.58) 2

Emerging Evidence on Lower Doses

While one pilot study suggested 4 g/L might be effective in low-severity cirrhosis (MELD 16-17), 2, 4 and a quality improvement study showed 6.5 g/L was non-inferior to 8.3 g/L, 5 the official guideline recommendation remains 6-8 g/L because dose-reduction studies have not been adequately powered for safety endpoints in high-risk populations. 2

Practical Implementation

Timing of administration:

  • Give albumin during or immediately after the paracentesis procedure 2
  • Infuse slowly to prevent cardiac overload, especially in patients with underlying cardiomyopathy 2

Critical pitfall to avoid:

  • Do not confuse this dosing with spontaneous bacterial peritonitis (SBP) albumin dosing, which is weight-based: 1.5 g/kg within 6 hours, then 1 g/kg on day 3 1, 2
  • Paracentesis albumin is calculated per liter removed, not per kilogram body weight 2

Monitoring for Complications

Watch for albumin-related adverse effects: 3

  • Fluid overload and pulmonary edema (most common concern)
  • Hypotension/tachycardia
  • Nausea/vomiting
  • Rigors, pyrexia, rash/pruritus

References

Guideline

Use of Albumin in Patients with Ascites

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Administración de Albúmina en Paracentesis de Gran Volumen

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Standardizing the Use of Albumin in Large Volume Paracentesis.

Journal of pharmacy practice, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.